October 23, 2020 -- Quest Diagnostics announced a jump in its third-quarter revenues (ended-September 30) on continued demand for COVID-19 testing and the rapid recovery of healthcare utilization. The company has also seen growth in demand for non-COVID testing.
For the third quarter, Quest posted revenue of $2.79 billion, up 42.5% compared with revenue of $1.95 billion in the same period the year before. The company's net income for the most recent period was $591 million, compared with $226 million in the third quarter of fiscal 2019.
Quest has performed over 22 million COVID-19 molecular and serology tests to date. The firm also noticed that its base testing volume, which excludes COVID-19 molecular and antibody testing, continued to recover throughout the third quarter.
Quest is raising its full-year 2020 outlook given its year-to-date performance and a clearer line of sight for both the base business and COVID-19 testing, the firm said.
When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.Yes, Keep Me Current